EVALUATION OF ROTARIX BOOSTER DOSE VACCINATION AT 9 MONTHS FOR SAFETY AND ENHANCED ANTI-ROTAVIRUS IMMUNITY IN ZAMBIAN CHILDREN: A RANDOMISED CONTROLLED TRIAL

EVALUATION OF ROTARIX BOOSTER DOSE VACCINATION AT 9 MONTHS FOR SAFETY AND ENHANCED ANTI-ROTAVIRUS IMMUNITY IN ZAMBIAN CHILDREN: A RANDOMISED CONTROLLED TRIAL

Comments are closed.

Facebook
Twitter
YouTube
LinkedIn
Instagram
NGOsource
Characterization of rotavirus strains responsible of breakthrough diarrheal disease among Zambian children using whole genome sequencing
July 30, 2024
EARLY HUMAN CYTOMEGALOVIRUS INFECTION AND ASSOCIATION WITH ORAL ROTAVIRUS VACCINE IMMUNOGENICITY IN ZAMBIA. 
September 5, 2024